ProteoMediX AG

ProteoMediX is a spinoff company of ETH Zurich and specialized in the development of novel biomarkers for the early detection of cancer and the personalized treatment thereof.
The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinical standard. This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.

Job Offers

There are currently no job offers.

Keep an eye on this company by adding it to your watchlist.

Reviews

No reviews yet
Help other job seekers and be the first one to write a review.

Location

ProteoMediX AG

Wagistr. 23
8952 Schlieren

http://www.proteomedix.com